Portfolio company
Coronado Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
About
This biopharmaceutical company develops and commercialises immunotherapy agents and treatments for patients with autoimmune diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Landos Biopharma
This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
Cullinan Oncology
This company develops therapies for patients living with autoimmune diseases and cancer.
Merida Biosciences
This company develops precision immunology therapies to treat patients suffering from autoimmune and allergic disorders.
ChemoCentryx
This biopharmaceutical company develops and commercialises orally administered small molecule medicines for patients with inflammatory, autoimmune diseases and cancer.
Coherus
This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.
